{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:43:54Z","timestamp":1794473034523,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,3,3]],"date-time":"2011-03-03T00:00:00Z","timestamp":1299110400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00259-011-1760-x","type":"journal-article","created":{"date-parts":[[2011,3,4]],"date-time":"2011-03-04T02:14:43Z","timestamp":1299204883000},"page":"1224-1236","source":"Crossref","is-referenced-by-count":98,"title":["68Ga-DOTATOC PET\/CT and somatostatin receptor (sst1\u2013sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax"],"prefix":"10.1007","volume":"38","author":[{"given":"Christian","family":"Boy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till A.","family":"Heusner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten D.","family":"Poeppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Redmann-Bischofs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Jentzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Brandau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Antoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bockisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Petersenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,3]]},"reference":[{"key":"1760_CR1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0165-6147(00)88988-9","volume":"16","author":"D Hoyer","year":"1995","unstructured":"Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PP, et al. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 1995;16:86\u20138.","journal-title":"Trends Pharmacol Sci"},{"key":"1760_CR2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev.ph.54.030192.002323","volume":"54","author":"MJ Lewin","year":"1992","unstructured":"Lewin MJ. The somatostatin receptor in the GI tract. Annu Rev Physiol 1992;54:455\u201368.","journal-title":"Annu Rev Physiol"},{"key":"1760_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","volume":"20","author":"YC Patel","year":"1999","unstructured":"Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 1999;20:157\u201398.","journal-title":"Front Neuroendocrinol"},{"key":"1760_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.mpa.0000226894.16817.e8","volume":"33","author":"N Ballian","year":"2006","unstructured":"Ballian N, Brunicardi FC, Wang XP. Somatostatin and its receptors in the development of the endocrine pancreas. Pancreas 2006;33:1\u201312.","journal-title":"Pancreas"},{"key":"1760_CR5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s002590100541","volume":"28","author":"JC Reubi","year":"2001","unstructured":"Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 2001;28:836\u201346.","journal-title":"Eur J Nucl Med"},{"key":"1760_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.052808.102215","volume":"49","author":"G Burnstock","year":"2009","unstructured":"Burnstock G. Autonomic neurotransmission: 60\u00a0years since sir Henry Dale. Annu Rev Pharmacol Toxicol 2009;49:1\u201330.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1760_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2009.04.003","volume":"156","author":"J Bosch Van Op den","year":"2009","unstructured":"Van Op den Bosch J, Adriaensen D, Van Nassauw L, Timmermans JP. The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review. Regul Pept 2009;156:1\u20138.","journal-title":"Regul Pept"},{"key":"1760_CR8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1043-2760(97)00168-9","volume":"8","author":"YC Patel","year":"1997","unstructured":"Patel YC, Srikant CB. Somatostatin receptors. Trends Endocrinol Metab 1997;8:398\u2013405.","journal-title":"Trends Endocrinol Metab"},{"key":"1760_CR9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002590050034","volume":"27","author":"JC Reubi","year":"2000","unstructured":"Reubi JC, Schar JC, Waser B, Wenger S, Heppeler A, Schmitt JS, et al. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 2000;27:273\u201382.","journal-title":"Eur J Nucl Med"},{"key":"1760_CR10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/105072501750362718","volume":"11","author":"R G\u00f6rges","year":"2001","unstructured":"G\u00f6rges R, Kahaly G, M\u00fcller-Brand J, M\u00e4cke H, Roser HW, Bockisch A. Radionuclide-labeled somatostatin analogues for diagnostic and therapeutic purposes in nonmedullary thyroid cancer. Thyroid 2001;11:647\u201359.","journal-title":"Thyroid"},{"key":"1760_CR11","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2967\/jnumed.108.053421","volume":"50","author":"M Gabriel","year":"2009","unstructured":"Gabriel M, Oberauer A, Dobrozemsky G, Decristoforo C, Putzer D, Kendler D, et al. 68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy. J Nucl Med 2009;50:1427\u201334.","journal-title":"J Nucl Med"},{"key":"1760_CR12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2967\/jnumed.109.070672","volume":"51","author":"A Rominger","year":"2010","unstructured":"Rominger A, Saam T, Vogl E, Ubleis C, la Foug\u00e8re C, F\u00f6rster S, et al. In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET\/CT: correlation with coronary calcium burden and risk factors. J Nucl Med 2010;51:193\u20137.","journal-title":"J Nucl Med"},{"key":"1760_CR13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.mce.2008.03.007","volume":"286","author":"PM Hagen van","year":"2008","unstructured":"van Hagen PM, Dalm VA, Staal F, Hofland LJ. The role of cortistatin in the human immune system. Mol Cell Endocrinol 2008;286:141\u20137.","journal-title":"Mol Cell Endocrinol"},{"key":"1760_CR14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/thy.2008.0389","volume":"19","author":"T Lincke","year":"2009","unstructured":"Lincke T, Singer J, Kluge R, Sabri O, Paschke R. Relative quantification of indium-111 pentetreotide and gallium-68 DOTATOC uptake in the thyroid gland and association with thyroid pathologies. Thyroid 2009;19:381\u20139.","journal-title":"Thyroid"},{"key":"1760_CR15","doi-asserted-by":"crossref","first-page":"E344","DOI":"10.1152\/ajpendo.00048.2003","volume":"285","author":"VA Dalm","year":"2003","unstructured":"Dalm VA, van Hagen PM, van Koetsveld PM, Achilefu S, Houtsmuller AB, Pols DH, et al. Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells. Am J Physiol Endocrinol Metab 2003;285:E344\u201353.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1760_CR16","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s002590100639","volume":"28","author":"M Hofmann","year":"2001","unstructured":"Hofmann M, Maecke H, B\u00f6rner R, Weckesser E, Sch\u00f6ffski P, Oei L, et al. Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. Eur J Nucl Med 2001;28:1751\u20137.","journal-title":"Eur J Nucl Med"},{"key":"1760_CR17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000265561","volume":"91","author":"J Ruf","year":"2010","unstructured":"Ruf J, Heuck F, Schiefer J, Denecke T, Elgeti F, Pascher A, et al. Impact of multiphase 68Ga-DOTATOC-PET\/CT on therapy management in patients with neuroendocrine tumors. Neuroendocrinology 2010;91:101\u20139.","journal-title":"Neuroendocrinology"},{"key":"1760_CR18","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2967\/jnumed.108.060236","volume":"50","author":"D Putzer","year":"2009","unstructured":"Putzer D, Gabriel M, Henninger B, Kendler D, Uprimny C, Dobrozemsky G, et al. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy. J Nucl Med 2009;50:1214\u201321.","journal-title":"J Nucl Med"},{"key":"1760_CR19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000167796","volume":"89","author":"VD Corleto","year":"2009","unstructured":"Corleto VD, Falconi M, Panzuto F, Milione M, De Luca O, Perri P, et al. Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. Neuroendocrinology 2009;89:223\u201330.","journal-title":"Neuroendocrinology"},{"issue":"Suppl 1","key":"1760_CR20","first-page":"99S","volume":"46","author":"R Barone","year":"2005","unstructured":"Barone R, Borson-Chazot F, Valkema R, Walrand S, Chauvin F, Gogou L, et al. Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship. J Nucl Med 2005;46 Suppl 1:99S\u2013106S.","journal-title":"J Nucl Med"},{"key":"1760_CR21","first-page":"37","volume":"54","author":"M Cremonesi","year":"2010","unstructured":"Cremonesi M, Botta F, Di Dia A, Ferrari M, Bodei L, De Cicco C, et al. Dosimetry for treatment with radiolabelled somatostatin analogues. A review. Q J Nucl Med Mol Imaging 2010;54:37\u201351.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1760_CR22","first-page":"61","volume":"54","author":"V Prasad","year":"2010","unstructured":"Prasad V, Baum RP. Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions. Q J Nucl Med Mol Imaging 2010;54:61\u20137.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1760_CR23","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2967\/jnumed.107.040378","volume":"48","author":"KP Zhernosekov","year":"2007","unstructured":"Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, et al. Processing of generator-produced 68Ga for medical application. J Nucl Med 2007;48:1741\u20138.","journal-title":"J Nucl Med"},{"key":"1760_CR24","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1088\/0031-9155\/55\/8\/016","volume":"55","author":"W Jentzen","year":"2010","unstructured":"Jentzen W. Experimental investigation of factors affecting the absolute recovery coefficients in iodine-124 PET lesion imaging. Phys Med Biol 2010;55:2365\u201398.","journal-title":"Phys Med Biol"},{"key":"1760_CR25","doi-asserted-by":"crossref","first-page":"15879","DOI":"10.1073\/pnas.0907843106","volume":"106","author":"CG Ziegler","year":"2009","unstructured":"Ziegler CG, Brown JW, Schally AV, Erler A, Gebauer L, Treszl A, et al. Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues. Proc Natl Acad Sci U S A 2009;106:15879\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1760_CR26","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1055\/s-2005-921092","volume":"37","author":"B Ueberberg","year":"2005","unstructured":"Ueberberg B, Tourne H, Redmann A, Walz MK, Schmid KW, Mann K, et al. Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland. Horm Metab Res 2005;37:722\u20138.","journal-title":"Horm Metab Res"},{"key":"1760_CR27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2007-1004574","volume":"40","author":"B Ueberberg","year":"2008","unstructured":"Ueberberg B, Unger N, Sheu SY, Walz MK, Schmid KW, Saeger W, et al. Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal gland. Horm Metab Res 2008;40:181\u20138.","journal-title":"Horm Metab Res"},{"key":"1760_CR28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2967\/jnumed.109.066662","volume":"51","author":"D Campana","year":"2010","unstructured":"Campana D, Ambrosini V, Pezzilli R, Fanti S, Labate AM, Santini D, et al. Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. J Nucl Med 2010;51:353\u20139.","journal-title":"J Nucl Med"},{"key":"1760_CR29","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00259-006-0110-x","volume":"33","author":"S Koukouraki","year":"2006","unstructured":"Koukouraki S, Strauss LG, Georgoulias V, Eisenhut M, Haberkorn U, Dimitrakopoulou-Strauss A. Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging 2006;33:1115\u201322.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1760_CR30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/ijc.10295","volume":"98","author":"S Froidevaux","year":"2002","unstructured":"Froidevaux S, Eberle AN, Christe M, Sumanovski L, Heppeler A, Schmitt JS, et al. Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model. Int J Cancer 2002;98:930\u20137.","journal-title":"Int J Cancer"},{"key":"1760_CR31","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00004728-198406000-00028","volume":"8","author":"RM Kessler","year":"1984","unstructured":"Kessler RM, Ellis Jr JR, Eden M. Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr 1984;8:514\u201322.","journal-title":"J Comput Assist Tomogr"},{"key":"1760_CR32","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s002590100541","volume":"28","author":"JC Reubi","year":"2001","unstructured":"Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 2001;28:836\u201346.","journal-title":"Eur J Nucl Med"},{"key":"1760_CR33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0924-977X(02)00108-6","volume":"12","author":"K Zilles","year":"2002","unstructured":"Zilles K, Palomero-Gallagher N, Grefkes C, Scheperjans F, Boy C, Amunts K, et al. Architectonics of the human cerebral cortex and transmitter receptor fingerprints: reconciling functional neuroanatomy and neurochemistry. Eur Neuropsychopharmacol 2002;12:587\u201399.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1760_CR34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/002215540405200310","volume":"52","author":"E Ludvigsen","year":"2004","unstructured":"Ludvigsen E, Olsson R, Stridsberg M, Janson ET, Sandler S. Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats. J Histochem Cytochem 2004;52:391\u2013400.","journal-title":"J Histochem Cytochem"},{"key":"1760_CR35","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1369\/jhc.2008.950998","volume":"56","author":"S Bhandari","year":"2008","unstructured":"Bhandari S, Watson N, Long E, Sharpe S, Zhong W, Xu SZ, et al. Expression of somatostatin and somatostatin receptor subtypes 1\u20135 in human normal and diseased kidney. J Histochem Cytochem 2008;56:733\u201343.","journal-title":"J Histochem Cytochem"},{"key":"1760_CR36","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.beem.2004.08.005","volume":"18","author":"MJ Low","year":"2004","unstructured":"Low MJ. Clinical endocrinology and metabolism. The somatostatin neuroendocrine system: physiology and clinical relevance in gastrointestinal and pancreatic disorders. Best Pract Res Clin Endocrinol Metab 2004;18:607\u201322.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1760_CR37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.24.2.114","volume":"24","author":"MG Bryant","year":"1983","unstructured":"Bryant MG, Bloom SR, Polak JM, Hobbs S, Domschke W, Domschke S, et al. Measurement of gut hormonal peptides in biopsies from human stomach and proximal small intestine. Gut 1983;24:114\u20139.","journal-title":"Gut"},{"key":"1760_CR38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1677\/joe.1.06082","volume":"187","author":"WH Smith","year":"2005","unstructured":"Smith WH, Nair RU, Adamson D, Kearney MT, Ball SG, Balmforth AJ. Somatostatin receptor subtype expression in the human heart: differential expression by myocytes and fibroblasts. J Endocrinol 2005;187:379\u201386.","journal-title":"J Endocrinol"},{"key":"1760_CR39","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0969-8051(94)90047-7","volume":"21","author":"WC Eckelman","year":"1994","unstructured":"Eckelman WC. The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals. Nucl Med Biol 1994;21:759\u201369.","journal-title":"Nucl Med Biol"},{"key":"1760_CR40","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.neurobiolaging.2006.08.005","volume":"28","author":"PT Meyer","year":"2007","unstructured":"Meyer PT, Elmenhorst D, Boy C, Winz O, Matusch A, Zilles K, et al. Effect of aging on cerebral A1 adenosine receptors: a [18F]CPFPX PET study in humans. Neurobiol Aging 2007;28:1914\u201324.","journal-title":"Neurobiol Aging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-011-1760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-011-1760-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-011-1760-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T20:17:41Z","timestamp":1560025061000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-011-1760-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,3]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1760"],"URL":"https:\/\/doi.org\/10.1007\/s00259-011-1760-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,3]]}}}